Terkko Navigator / Joint Bone Spine

Treatment adherence during the COVID-19 pandemic and the impact of confinement on disease activity and emotional status: a survey in 644 rheumatic patients

Can SARS-CoV-2 trigger reactive arthritis?

Comment on “Local sacroiliac injections in the treatment of spondyloarthritis. What is the evidence?” by Wendling et al. Joint Bone Spine 2020; 87:209-213

Progress towards improved non-pharmacological management of fibromyalgia

UltraSound Evaluation in Follow-up of Urate-Lowering therapy in gout phase 2 (USEFUL-2): duration of flare prophylaxis

Trends in the manifestations of 9754 gout patients in a Chinese clinical center: A 10-year observational study

Answer to Vieira et al « Cytokine profile as a prognostic tool in coronavirus disease 2019 ». Joint Bone Spine 2020. Doi:10.1016/j.jbspin.2020.09.006

Pregnancy outcome is favorable in patients with rheumatic diseases under specialized surveillance – Data from the Tuebingen registry for pregnancy in rheumatic diseases in 238 pregnancies

Pregnancy rates and outcomes in early axial spondyloarthritis: an analysis of the DESIR cohort

The “step-sign”: a new ultrasound sign of aseptic osteonecrosis of the femoral head

Recommendations of the French Society of Rheumatology on pharmacological treatment of knee osteoarthritis

Attainment of the Patient-acceptable Symptom State in 548 patients with rheumatoid arthritis: influence of demographic factors

Adjuvant-induced arthritis is a relevant model to mimic coronary and myocardial impairments in rheumatoid arthritis

COPA syndrome, 5 years after: where are we?

Serum calprotectin is increased in early axial spondyloarthritis with sacroiliitis and objective signs of inflammation: results from the DESIR cohort

New era for outcomes and management of rheumatoid arthritis: facing the individualized treatment challenge

Bone changes in early inflammatory arthritis assessed with High-Resolution peripheral Quantitative Computed Tomography (HR-pQCT): a 12-month cohort study

Beyond sicca symptoms: osteomalacia secondary to renal tubular acidosis in Sjogren syndrome

Answer to Checa « Coexistence of gout and chondrocalcinosis instead? », Joint Bone Spine 2020. DOI:10.1016/j.jbspin.2020.07.007

2020 French recommendations on the management of septic arthritis in an adult native joint

Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs in the French cohort ESPOIR

Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA

Coexistence of gout and chondrocalcinosis instead? Comment on: “Monosodium urate deposition in the articular cartilage and meniscus can mimic chondrocalcinosis” by Bousson et al. Joint Bone Spine 2020, 87:95-96

“Y” Sign in Spinal Epidural Lipomatosis

Risk factors associated with initiation of a biologic disease modifying anti-rheumatic drug in patients with rheumatoid arthritis: a nested case-control study on 34,925 patients

Answer to Tahri et al «Retinoid Hyperostosis, an overlooked cause of atypical sacroiliac pain in young patients: a pharmacovigilance survey». Joint Bone Spine 2020. DOI: 10.1016/j.jbspin.2020.06.023

Tendon paratenon involvement in patients with gout: an under-recognized ultrasound feature of tendinous gout?

Pop a Pill or Give myself a Shot? Patient perspectives of disease-modifying anti-rheumatic drug (DMARD) choice for rheumatoid arthritis (RA)

Primary total hip arthroplasty followed by a pubic post-fracture osteolysis simulating malignancy

Retinoid Hyperostosis, an overlooked cause of atypical sacroiliac pain in young patients : a pharmacovigilance survey. Comment on : “Cervical myelopathy revealing a unique case of Retinoid Hyperostosis” by Pijnenburg et al. Joint Bone Spine 2020;86:6

Gradual Reduction of Tophaceous Deposits during Urate-lowering Therapy

Extended myositis-specific and -associated antibodies profile in systemic sclerosis: a cross-sectional study

Comparison of paediatric and adult classification criteria in juvenile idiopathic arthritis during the transition from paediatric to adult care

Opioid epidemic: does rheumatological practice favors risk for patients? National survey on rheumatologists' opioid prescriptions and compliance to guidelines for strong opioid prescription

Aortic Involvement in Giant Cell Arteritis

Leptomeningeal involvement in a patient with systemic lupus erythematosus infecting by COVID-19

Absence of association between inflammatory dietary pattern and low trauma fractures: results of the French cohort NutriNet-Santé

Predictors of disease flare after discontinuation of concomitant methotrexate in Japanese patients with rheumatoid arthritis treated with tocilizumab

Toward a tailored therapeutic prescription for patients with axial spondyloarthritis

Cobalt hip prosthesis intoxication mimicking an autoimmune disease

Epigenetics of spondyloarthritis

Answer to Grzelecki et al, Joint Bone Spine 2020, doi:10.1016/j.jbspin.2020.04.022

Experience of pain is correlated to treatment profile in patients with rheumatoid arthritis. Differentiating 5 clusters of patients in a national cohort of 1100 women with rheumatoid arthritis

Effectiveness of a Short Functional Restoration Program for Patients with Chronic Low Back Pain: a cohort study of 193 Patients

Consequences of spinal ankylosis on bone trabecular fragility assessed on CT scans in patients with ankylosing spondylitis. A retrospective study

Janus kinases inhibitors for treating patients with rhupus

Comment on “Comparison of several biomarkers (MMP-2, MMP-9,the MMP-9 inhibitor TIMP-1, CTX-II, calprotectin, andCOMP) in the synovial fluid and serum of patients withand without septic arthritis” Joint Bone Spine. 2019; 86(2):261-262

Appropriateness of laboratory tests in the diagnosis of inflammatory rheumatic diseases among patients newly referred to rheumatologists

Bruton’s Tyrosine Kinase in Systemic Lupus Erythematosus

Metabolomics in the Development and Progression of rheumatoid arthritis: A Systematic Review